¥4781.00
¥0.00 (0.00%)
End-of-day quote: 06/01/2024
TSE:4519
Chugai Pharmaceutical Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $820.34 | $850.79 | 0.00% | 9 | $738.64B |
| JNJ | Johnson & Johnson | NYSE | Outperform | $146.67 | $172.51 | 0.00% | 3 | $352.99B |
| ABBV | AbbVie | NYSE | Outperform | $161.24 | $182.12 | 0.00% | 11 | $284.73B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.90 | £134.03 | 0.00% | 16 | £188.97B |
| ROG | Roche Holding | SWX | Hold | CHF231.00 | CHF277.53 | 0.00% | 9 | CHF186.49B |
| PFE | Pfizer | NYSE | Outperform | $28.66 | $31.92 | 0.00% | 6 | $162.40B |
| SAN | Sanofi | ENXTPA | Outperform | 89.76€ | 108.19€ | 0.00% | 9 | 112.21€B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $980.16 | $1.04k | 0.00% | 8 | $105.75B |
| GSK | GSK | LSE | Outperform | £17.67 | £20.35 | 0.00% | 12 | £72.04B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $41.09 | $53.19 | 0.00% | 10 | $83.29B |
